Waltham MA, December 29, 2014 -- TRA360 (www.tra360.com) is a professional writing services company that has unique capabilities when it comes to regulatory writing for the life sciences.

Regulatory writing and medical writing are not for the faint of heart. The risk of non-compliance can destroy product potential, ruin corporate and professional reputations, and be detrimental to the bottom line. For more than 20 years, life sciences companies large and small have come to rely on TRA360 for their regulatory medical writing needs. They know that TRA360 will assemble the right team of people, with the right therapeutic domain expertise, to complete high-quality, reliable regulatory documentation every single time.

“Our location has put us at the very center of the life sciences industry,” said Timothy Rosa, President and CEO of TRA360. “Over the years, this has allowed us to assemble a large reservoir of regulatory writing talent with particular capabilities in clinical trial documentation for medical devices, drugs, and biologics.”

According to Rosa, TRA360 has built its reputation on being able to work collaboratively with their clients to complete the many large, complex documents required by the US FDA, EU EMEA, and Japanese PMDA.

For more information about TRA360 and their expertise in regulatory writing and medical writing for the life sciences, visit www.TRA360.com

About TRA 360 professional writing services
Started in 1991 by founder, Timothy Rosa, TRA360 has grown to be a professional writing services powerhouse not only in the Boston area but globally. Whether it’s delivering awarding winning regulatory writing and medical writing to company giants such as Bayer Healthcare, Sanofi-avent is, Takeda, and Vertex, or providing technical writing for technology companies worldwide, TRA360 is committed to delivering only the highest quality work on time and on budget. For more information about TRA360, visit http://www.TRA360.com